SEC Filing Details
Document Details
Form
Filing Date
Apr 27, 2026
Document Date
Apr 23, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Corvus Pharmaceuticals
Issuer
Corvus Pharmaceuticals, Inc.
Filer
CHAN ANDREW C.
